←Back to Expert Scholars
Translational Medicine / 转化医学DCIS Active Surveillance
Shelley Hwang
MD, MPH
🏢Duke Cancer Institute🌐USA
Chief, Breast Surgery
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Shelley Hwang leads the COMET trial evaluating active monitoring versus guideline-concordant treatment for low-risk DCIS. Her work is central to the paradigm shift toward DCIS de-escalation. She directs breast surgery at Duke.
Share:
🧪Research Fields 研究领域
DCIS
active monitoring
COMET trial
breast surgery
de-escalation
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Shelley Hwang 的研究动态
Follow Shelley Hwang's research updates
留下邮箱，当我们发布与 Shelley Hwang（Duke Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment